BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36484934)

  • 21. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of the Tumor-Node-Metastasis Staging System for Differentiated Thyroid Carcinoma by Considering Extra-Thyroidal Extension and Lateral Cervical Lymph Node Metastasis.
    Kim M; Kim WG; Jeon MJ; Kim HK; Yi HS; Kim ES; Kim BH; Kim WB; Shong YK; Kang HC; Kim TY
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):149-156. PubMed ID: 32207275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New proposed tumor-node-metastasis staging system for medullary thyroid carcinoma based on the Surveillance, Epidemiology, and End Results database.
    Wang M; Hu D; Zeng W; Chen S; Huang Y; Zhou L; Zhou W; Wei W; Zhang C; Liu Z; Guo L
    Am J Transl Res; 2020; 12(6):2703-2710. PubMed ID: 32655802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-Analysis.
    Lechner MG; Bernardo AC; Lampe A; Praw SS; Tam SH; Angell TE
    Oncologist; 2021 Feb; 26(2):e251-e260. PubMed ID: 32864832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
    Jiang W; Zhao B; Li Y; Qi D; Wang D
    BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage II esophageal carcinoma: the significance of T and N.
    Killinger WA; Rice TW; Adelstein DJ; Medendorp SV; Zuccaro G; Kirby TJ; Goldblum JR
    J Thorac Cardiovasc Surg; 1996 May; 111(5):935-40. PubMed ID: 8622316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
    Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
    Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified staging classification of gallbladder carcinoma on the basis of the 8
    Wang J; Bo X; Shi X; Suo T; Xin Y; Nan L; Wang C; Ni X; Liu H; Pan H; Shen S; Li M; Lu P; Zhang D; Wang Z; Wang Y; Liu H
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):527-533. PubMed ID: 31630931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
    Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
    Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database.
    Lin JX; Lin JP; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM
    Eur J Surg Oncol; 2018 Aug; 44(8):1205-1211. PubMed ID: 29804693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer.
    Shaha AR; Migliacci JC; Nixon IJ; Wang LY; Wong RJ; Morris LGT; Patel SG; Shah JP; Tuttle RM; Ganly I
    Surgery; 2019 Jan; 165(1):6-11. PubMed ID: 30415873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the predicted impact of changes to the AJCC/TMN staging system for differentiated thyroid cancer (DTC): A prospective observational study of patients in South East Scotland.
    Hulse K; Williamson A; Gibb FW; Conn B; Nixon IJ
    Clin Otolaryngol; 2019 May; 44(3):330-335. PubMed ID: 30720920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance for colorectal carcinoid tumors based on the 8th edition TNM staging system.
    Gong P; Chen C; Wang Z; Zhang X; Hu W; Hu Z; Li X
    Cancer Med; 2020 Nov; 9(21):7979-7987. PubMed ID: 32897004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma.
    Zhang XF; Xue F; He J; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    HPB (Oxford); 2021 Sep; 23(9):1456-1466. PubMed ID: 33814298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
    Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
    Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
    Inoue K; Sato M; Fujimura S; Sakurada A; Takahashi S; Usuda K; Kondo T; Tanita T; Handa M; Saito Y; Sagawa M
    J Thorac Cardiovasc Surg; 1998 Sep; 116(3):407-11. PubMed ID: 9731782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
    Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
    BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.